Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
2 investors
Avionova develops bioastronautics research and technology commercialization solutions, serving the aerospace and medical sectors with expertise in dual-use product strategy and commercialization.
2 investors
2 investors
Aviwell develops microbiota-based feed solutions to improve animal health and growth for livestock and fish producers in the agri-food industry. It uses a hybrid AI/ML discovery platform combining in-silico and in-vivo approaches, drawing on research into the gut-brain microbiota axis, to create natural direct fed microbials.
2 investors
AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.
2 investors
Axovia Therapeutics develops gene therapies for ciliopathies, with a lead program using an adeno-associated virus (AAV9) to deliver a functional copy of the BBS1 gene in patients with Bardet-Biedl Syndrome. The company aims to treat genetic forms of obesity and blindness associated with these disorders.
2 investors
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
2 investors
Azadyne is a UK biotech company and spin-out from Trinity College Dublin developing therapeutics based on tRNA modification and epigenetic regulation of cellular protein synthesis. Its work targets the treatment of disease through this novel mechanism.
2 investors
Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.
2 investors
Clinical-stage biopharmaceutical company developing best-in-class aryl hydrocarbon receptor agonists.
2 investors
Azulene Labs develops physics-powered molecular discovery technology. The company serves scientists and engineers working in molecular research and discovery.
2 investors
Bambusa Therapeutics develops bispecific antibodies for immunological and inflammatory (I&I) disorders, using antibody engineering to target multiple I&I indications. The clinical-stage biotech company serves patients across a range of I&I diseases.
2 investors
Base Therapeutics is a biopharmaceutical company working in the cell and gene therapy field, developing therapeutic products and research reagents and running clinical research projects for clients such as pharmaceutical companies, research institutes, universities, and hospitals. The page consists of job listings for operations, business development, sales, medical affairs, and R&D roles.
2 investors
BBy develops a condensed breast milk product and process that preserves bioactive immunological properties for hospital distribution. The company serves hospitals, lactating mothers with supply challenges, and families needing access to safe, affordable breast milk nutrition.
2 investors
BC Platforms provides AI-enabled, federated data technology and predictive analytics that give healthcare and life sciences organizations access to real-world patient and genomic data for drug development and precision medicine. It serves pharmaceutical companies and healthcare organizations across the US, Europe, Asia-Pacific, and the Middle East.
2 investors
Beaubrain develops AI-powered diagnostic and digital therapeutic solutions for dementia, focusing on early detection through biomarker prediction and brain health management. The company serves healthcare providers and patients at risk for Alzheimer's disease, leveraging partnerships with Samsung Medical Center for clinical validation and drug development.
2 investors
BEIT provides physics-based computational approaches for drug discovery, embedding scientists with expertise in physics, mathematics, and engineering into pharmaceutical research programs.
2 investors
Online gambling platform offering slots, live-dealer table games, crash-style games, and sports betting to players in Azerbaijan. Operated by Carlitta N.V. under a Curaçao license, with bonuses, multilingual interface, and mobile (Android APK / iOS) access.
2 investors
BetaGlue develops solutions for the medical device and healthcare sector, supported by a board of directors with expertise in interventional radiology, nuclear medicine, and clinical operations.
2 investors
Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol). Its lead candidate, BTQ1902, is a timolol suspension in development for elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
2 investors
Better Juice develops an enzymatic technology that reduces natural sugars in fruit juices and other fruit-based foods and beverages by up to 80% while retaining flavor and nutrients, using natural enzymes in non-GMO microorganisms as a pass-through production step. It sells to food and beverage manufacturers seeking to create low-sugar, clean-label products.
2 investors
Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types. The compound demonstrates clinical benefit in extending overall survival and reducing severe chemotherapy-related neutropenia.
2 investors
BH Therapeutics is a drug development company that uses structure-based rational drug design to identify structural limitations in existing therapies and design novel chemical scaffolds to address them. It develops a pipeline of medicines and conducts clinical trials.
2 investors
Biftek develops a microorganism-based growth medium supplement for cultured meat production, offering a lower-cost alternative to fetal bovine serum. The product targets the cultivated meat industry, aiming to reduce the cost, water use, land use, and emissions associated with meat production.
2 investors